Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
The British Journal of Dermatology|May 25, 2010
Degradation of eschar from venous leg ulcers using a recombinant chymotrypsin from Lucilia sericataG Telford, A P Brown, R A M Seabra, et al.
Infection and Immunity|January 10, 1998
The Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-L-homoserine lactone has immunomodulatory activityG Telford, D Wheeler, P Williams, et al.
European Journal of Immunology|May 1, 2016
Distinct IL-7 signaling in recent thymic emigrants versus mature naïve T cells controls T-cell homeostasisHye Kyung Kim, Adam T Waickman, Ehydel Castro, et al.
Frontiers in Immunology|March 5, 2021
Surface NKG2C Identifies Differentiated αβT-Cell Clones Expanded in Peripheral BloodElena I Kovalenko, Ivan V Zvyagin, Maria A Streltsova, et al.
Annals of Clinical and Laboratory Science|October 29, 2005
Histone deacetylase inhibitor pharmacodynamic analysis by multiparameter flow cytometryEun Joo Chung, Sunmin Lee, Edward A Sausville, et al.
International Journal of Molecular Sciences|January 24, 2019
Recurrent Stimulation of Natural Killer Cell Clones with K562 Expressing Membrane-Bound Interleukin-21 Affects Their Phenotype, Interferon-γ Production, and LifespanMaria A Streltsova, Sofya A Erokhina, Leonid M Kanevskiy, et al.
Oncotarget|December 17, 2014
ROS production, intracellular HSP70 levels and their relationship in human neutrophils: effects of ageElena I Kovalenko, Anna A Boyko, Victor F Semenkov, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2013
CD200-expressing human basal cell carcinoma cells initiate tumor growthChantal S Colmont, Antisar Benketah, Simon H Reed, et al.
Cancers|May 16, 2023
Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib ResistanceTapan K Maity, Eun Young Kim, Constance M Cultraro, et al.
Plos Biology|February 4, 2010
Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1Shoba Amarnath, Carliann M Costanzo, Jacopo Mariotti, et al.
Pageof 11